Success Metrics

Clinical Success Rate

100.0%

Based on 5 completed trials

Completion Rate

100%(5/5)

Active Trials

0(0%)

Results Posted

20%(1 trials)

Phase Distribution

Ph phase_2

33%

Ph not_applicable

67%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution6 total trials

Phase 2Efficacy & side effects

2(33.3%)

N/ANon-phased studies

4(66.7%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

5 of 5 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(5)

Other(1)

Detailed Status

Completed5

unknown1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 2

Trials by Phase

Phase 22 (33.3%)

N/A4 (66.7%)

Trials by Status

completed583%

unknown117%

Recent Activity

0 active trials

Showing 5 of 6

completednot_applicable

Gluten Challenge in Celiac Disease

NCT02464150

completedphase_2

A Study to Evaluate the Efficacy and Safety of AMG 714 in Adult Patients With Celiac Disease

NCT02637141

completednot_applicable

Clinical Trials (6)

Showing 6 of 6 trials

NCT02464150Not Applicable

Gluten Challenge in Celiac Disease

Completed

NCT02637141Phase 2

A Study to Evaluate the Efficacy and Safety of AMG 714 in Adult Patients With Celiac Disease

Completed

NCT01932476Not Applicable

Gluten Immunity and Islet Autoimmunity in Type-1 Diabetes

Completed

NCT02472704Not Applicable

Lymphocytic Enteritis and Suspected Coeliac Disease: Gluten vs Placebo

Completed

NCT02280746Not Applicable

Gluten for Autism Spectrum Disorders

Unknown

NCT01100099Phase 2

HLA-DQ2-gliadin Tetramer for Diagnosis of Celiac Disease

Completed

All 6 trials loaded

Drug Details

Intervention Type: DIETARY SUPPLEMENT
Total Trials: 6